A multivariate logistic regression analysis (27) previously indicated that positive anti-MDA5, elevated CRP, and decreased counts of lymphocyte can provide a precise prediction for RP-ILD in patients with CADM. This evidence concerns the gene IFIH1 and clinically amyopathic dermatomyositis.